Temovate


INDICATIONS

Clobetasol propionate ointment and emollient cream are super-high potency corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 grams per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis. Use in children under 12 years of age is not recommended.

Temovate & Emollient: In the treatment of moderate to severe plaque-type psoriasis, TEMOVATE Emollient applied to 5% to 10% of body surface area can be used up to 4 consecutive weeks. The total dosage should not exceed 50 g/week. When dosing for more than 2 weeks, any additional benefits of extending treatment should be weighed against the risk of HPA suppression. Treatment beyond 4 consecutive weeks is not recommended. Patients should be instructed to use TEMOVATE Emollient for the minimum amount of time necessary to achieve the desired results (see PRECAUTIONS). Use in pediatric patients under 16 years of age has not been studied.

As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.


DOSAGE AND ADMINISTRATION

Ointment and Emollient Cream: Apply a thin layer of Clobetasol Propionate USP to the affected skin areas twice daily and rub in gently and completely.

Clobetasol Propionate Ointment and Emollient Cream are super-high potency topical corticosteroids; therefore, treatment should be limited to 2 consecutive weeks, and amounts greater than 50 grams per week should not be used.

As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Clobetasol Propionate Ointment USP and Clobetasol Propionate Emollient Cream USP should not be used with occlusive dressings.

Temovate & Emollient (only): In moderate to severe plaque-type psoriasis, TEMOVATE & Emollient applied to 5% to 10% of body surface area can be used up to 4 weeks. The total dosage should not exceed 50 g/week. When dosing for more than 2 weeks, any additional benefits of extending treatment should be weighed against the risk of HPA suppression.

HOW SUPPLIED

Ointment: Clobetasol Propionate Ointment USP, 0.05% is supplied in 15 g, 30 g, and 45 g tubes.

Temovate & Emollient: Temovate & Emollient, 0.05% is supplied in 15-g (NDC 0173-0454-01), 30-g (NDC 0173-0454-02), and 60-g (NDC 0173-0454-03) tubes.

STORAGE

Store at controlled room temperature 15°-30° C( 59°-86° F). Clobetasol Propionate Ointment and Emollient Cream should not be refrigerated.

CAUTION: Federal law prohibits dispensing without prescription.